A patient with elevated Lp(a): What is current clinical practice to manage this condition?

10' education - May 27, 2016 - Innsbruck, Germany - Prof. Klaus G. Parhofer, MD - University of Munich, Germany - FRIDAY, MAY 27, 2016, lunch symposium at Lp(a) symposium prior to EAS

Video navigation menu

Elevated Lp(a) levels as an independent and additive CV risk factor 0:41
When to treat a patient with elevated Lp(a)? 1:20
Currently available drugs to lower Lp(a) levels 2:07
Effect of lipoprotein apheresis on Lp(a) levels 5:32
Does lowering Lp(a) levels improve clinical outcomes? 6:21
How are patients currently treated - treatment algorithm 9:10

Disclosures

Prof. Klaus G. Parhofer, MD – is Professor of Endocrinology and Metabolism at the University of Munich in Germany.

Funding

The PACE foundation received funding for this session via an unrestricted educational grant from Amgen

A patient with elevated Lp(a): What is current clinical practice to manage this condition?

Video navigation menu

Disclosures

Funding

View the slides of this presentation